B cells, antibody-secreting cells, and virus-specific antibodies respond to herpes simplex virus 2 reactivation in skin-Reference-Cited by-同舟云学术

B cells, antibody-secreting cells, and virus-specific antibodies respond to herpes simplex virus 2 reactivation in skin

Published:2021-05-03 Issue:9 Volume:131 Page:
ISSN:1558-8238
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Ford Emily S.^ORCID,Sholukh Anton M.^ORCID,Boytz RuthMabel,Carmack Savanna S.,Klock Alexis,Phasouk Khamsone,Shao Danica,Rossenkhan Raabya,Edlefsen Paul T.^ORCID,Peng Tao,Johnston Christine,Wald Anna^ORCID,Zhu Jia^ORCID,Corey Lawrence^ORCID

Funder

NIAID

National Institutes of Health

Fred Hutchinson Cancer Research Center

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://www.jci.org/articles/view/142088/files/pdf

Reference67 articles.

1. Virologic Characteristics of Subclinical and Symptomatic Genital Herpes Infections

2. Recurrence Rates in Genital Herpes after Symptomatic First-Episode Infection

3. Mathematical Modeling Predicts that Increased HSV-2 Shedding in HIV-1 Infected Persons Is Due to Poor Immunologic Control in Ganglia and Genital Mucosa

4. Mucosal host immune response predicts the severity and duration of herpes simplex virus-2 genital tract shedding episodes

5. Virus-specific CD8+ T cells accumulate near sensory nerve endings in genital skin during subclinical HSV-2 reactivation

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety of non-replicative and oncolytic replication-selective HSV vectors;Trends in Molecular Medicine;2024-08

2. Vaccine value profile for herpes simplex virus;Vaccine;2024-07

3. Spatial transcriptomics reveals the interplay between cancer and immune cells directed by MXene quantum dots;Nano Today;2024-06

4. Impact of CD4+ T lymphocytes on the cellular and molecular milieu of the vaginal mucosa following HSV-2 challenge of immune guinea pigs;Virology;2023-11

5. Boosting of vaginal HSV-2-specific B and T cell responses by intravaginal therapeutic immunization results in diminished recurrent HSV-2 disease;Journal of Virology;2023-09-28